Missouri Senate Bill SB884

Missouri 2026 Regular Session

• Introduced: 1/7/26
• Introduced: 12/31/69
• Refer: 1/8/26

Caption

Provides that the practice of optometry shall include the use of injectable agents and surgical procedures for certain purposes

Impact

If enacted, SB884 would significantly alter state laws regarding the practice of optometry in Missouri. It allows licensed optometrists to perform a wider range of procedures, including injections and surgeries that were previously restricted. This change is anticipated to enhance patient care by enabling optometrists to offer comprehensive eye care services under one roof, potentially increasing accessibility to treatments for eye conditions. However, this move may also necessitate further training and certification for optometrists to ensure patient safety and effective care.

Summary

Senate Bill 884 seeks to expand the definition of the 'practice of optometry' to include the use of injectable agents and certain surgical procedures for treatment of ocular conditions. The bill proposes to repeal the existing section 336.010 of the Missouri Revised Statutes and replace it with updated regulations that authorize optometrists to engage in these enhanced practices, thus broadening the scope of care that can be provided by optometric professionals. The legislation specifically outlines diagnostic, treatment, and surgical responsibilities, aiming to improve patient care and access to necessary eye treatments.

Contention

The introduction of SB884 has sparked discussions regarding the implications of allowing optometrists to perform surgical procedures. Advocates argue that such measures would reduce the burden on ophthalmologists and provide patients with more immediate care options. Detractors, however, raise concerns about the adequacy of training and the potential risks involved in expanding the scope of practice for optometrists. They fear that this could lead to an over-extension of services beyond their training, thus compromising patient safety. The debate continues as stakeholders, including health professionals and patient advocacy groups, navigate the complexities of this legislation.